
$4.2B+16% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $4.2B in 2025, compounding +15% a year since 2022 though the pace has cooled. The trailing twelve months are already running at $4.6B, ahead of the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
$417M−78% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Net income was $417M in 2025, against $1.9B the year before. Earnings per share moved -87% over the last twelve months. Trailing twelve-month profit stands at $249M.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
+15.8%revenue growth, FY 2025
→Revenue grew +16% in 2025 against a five-year average of +21%. Earnings went the other way (-78%) even as sales grew, so margins compressed: costs rose faster than revenue.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
$1.3B+33% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow was $1.3B in 2025, compounding +42% a year since 2022. That is the most cash the business has ever thrown off in a year. The trailing twelve months stand at $1.3B.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→30 cents of every sales dollar became free cash in 2025, up 14 points since 2022 - the best conversion in its filed history.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→The biggest claim on each sales dollar is research and development, at 34% of revenue (stock compensation 21%, capital spending 1%).
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→Operating margin widened 11 points to 8% since 2022. After everything, 10 cents of each sales dollar reaches net profit. PINS doesn't tag a gross-profit line in its filings, so the chart starts at operating margin.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→ROE of 9% and ROCE of 6% sit close together, so the returns come from the business itself rather than from borrowing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
56.4xP/E today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 56.4x earnings, the market is paying about what it has typically paid PINS's own 3-year median of 53.3x. Neither a bargain nor a stretch by its own standard.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
11.1%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys 11.1% of annual free cash flow, more than its 7-year median of 2.8% - the cash is cheaper than usual.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Debt isn't clearly tagged in PINS's filings, so treat the balance sheet with extra care rather than assuming zero.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The company's own capital shrank from $3.1B in 2023 to $2.9B (-6%). Buybacks or losses are drawing the buffer down - the distinction matters.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Shareholders received $927M in buybacks in 2025. Stock compensation issued $880M of new shares in the same year, offsetting 95% of that.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The share count shrank 1.5% in 2025. Buybacks are concentrating your ownership: the same business, split fewer ways.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→PINS earns 6.4% on the capital it employs, below the 10% most investors treat as the cost of capital.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→PINS issued +64% more shares from 2019 to 2025, but revenue per share still rose +126%. The dilution bought more growth than it cost existing holders.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Insiders sold $29M on the open market and bought nothing. Many sales are pre-scheduled diversification rather than a view on the price. A further 30 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30